Loading…
MGRX
Mangoceuticals Inc
NASDAQ· Healthcare· Health Information Services· CUSIP 56270V205
$0.40+0.50%Price as of Aug 29, 18:47 UTC · updated once a day, after the close
Key metrics
- Market cap
- $8.67M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.6x
- Dividend yield
- —
- Payout
- —
- EPS
- -$1.00
- ROE
- -95.10%
- Profit margin
- 0.00%
- Revenue growth
- -59.10%
- Beta
- —
- 52-week high
- $2.75
- 52-week low
- $0.16
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -97.3% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 3 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Year-end price | $0.74 | $2.42 | $4.16 | |
| P/S | 20.3x | 27.5x | 20.3x | 8.9x |
| P/B | 0.9x | 0.8x | 0.9x | 8.4x |
| EPS | -$2.17 | -$4.80 | -$8.58 | |
| Profit margin | -1413.63% | -4526.76% | -1413.63% | -1259.40% |
| ROE | -135.80% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| XWELXWELL, Inc. | $1.01 | — | 20.6x | — | -361.36% | $8.68M |
| EVGNEvogene Ltd. | $0.55 | — | — | — | -182.75% | $8.68M |
| NDRAENDRA Life Sciences Inc. | $5.80 | — | 1.4x | — | -152.04% | $8.7M |
| CODXCo-Diagnostics, Inc. | $1.21 |
About the company
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
- 3
- Dallas, United States
Company description provided by Yahoo Finance.